Image: Emiliano Ponzi
What is PPA?
PPA (Primary Progressive Aphasia) is a clinical syndrome that is diagnosed when the following features are present:
- A disorder of spoken or written language (i.e., aphasia)
- The aphasia is caused by a degenerative brain disease (i.e., progressive)
- The aphasia is initially the most salient feature and the chief cause of daily living limitations (i.e., primary)
Clinicians and Investigators
Clinicians and investigators who have registered and passwords may log in to access additional site features:
- Search Patient Data
- Add or Modify data related to their patients
- Add or Modify Links
- Add or Modify resources/support groups at their centers
- Add or Modify clinical trials at their centers
- Modify personal Information
- Join prospective studies (some by invitation only; some open to all qualified researchers and clinicians)
Founding Members:
| Sharar Arzy, MD, Jerusalem, Israel | Sandra Black, MD, Toronto, Canada |
| Bradley Boeve, MD, Rochester, USA | Stefano Cappa, MD, Milano, Italy |
| Paulo Caramelli, MD, Belo Horizonte, Brazil | Brad Dickerson, MD, Boston, USA |
| Nina Dronkers, MD, Martinez, USA | Maria Luisa Gorno Tempini, MD, PhD, San Francisco, USA |
| Murray Grossman, MD, EdD, Philadelphia, USA | John R. Hodges, MD, Sydney, Australia |
| Nancy Johnson, PhD, Chicago, USA | Andrew Kertesz, MD, London, Canada |
| Mario Lopez-Gomez, MD, Mexico City, Mexico | Facundo Manes, MD, Buenos Aires, Argentina |
| PS Mathuranath, MD, Trivandrum, India | Marsel Mesulam, MD, Chicago, USA |
| Bruce Miller, MD, San Francisco, USA | Evdokia Nikolaidou, MD, Thessaloniki, Greece |
| Ricardo Nitrini, MD, San Paulo, Brazil | Katya Rascovsky, PhD, Philadelphia, USA |
| Jonathan Rohrer, MD, London, United Kingdom | Emily Rogalski, PhD, Chicago, USA |
| Marc Teichmann, MD, Paris, France | Cynthia Thompson, PhD, Evanston, USA |
| Magda Tsolaki, MD, Thessaloniki, Greece | Rik Vandenberghe, MD, Leuven, Belgium |
| Sandra Weintraub, PhD, Chicago, USA | Guiseppe Zappala, MD, Catania, Italy |